TELA Bio
TELA
36 hedge funds and large institutions have $16.7M invested in TELA Bio in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 9 closing their positions.
46,400% more call options, than puts
Call options by funds: $465K | Put options by funds: $1K
250% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8.3% less ownership
Funds ownership: 68.37% → 60.07% (-8.3%)
14% less funds holding
Funds holding: 42 → 36 (-6)
49% less capital invested
Capital invested by funds: $32.5M → $16.7M (-$15.8M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$230K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$81.2K |
| 3 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$47.2K |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$28.2K |
| 5 |
DWM
Ducere Wealth Management
Newport Beach,
California
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$383K |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$337K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$87K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$67.8K |
| 5 |
Renaissance Technologies
New York
|
-$66.1K |
TELA Hedge Fund Activity: Q1 2026 in Review
36 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2026, worth a combined $16.7M — down 49% from $32.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of TELA and 4 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 14 added.
The largest buyer was Stonepine Capital Management, adding an estimated $230K. The largest seller was UBS Group, cutting an estimated $383K.
- 36 institutional investors held TELA Bio (TELA) as of Q1 2026, down from 42 in Q4 2025.
- Funds reported $16.7M of TELA Bio stock for Q1 2026, down 49% quarter-over-quarter.
- 4 funds opened new TELA Bio positions in Q1 2026 and 9 closed out, a net change of -5 holders.
- The largest TELA Bio buyer in Q1 2026 was Stonepine Capital Management, an estimated $230K added.
- The largest TELA Bio seller in Q1 2026 was UBS Group, an estimated $383K sold.
Based on aggregated 13F filings for Q1 2026.